CytomX(CTMX) - 2022 Q3 - Earnings Call Transcript

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Chris Ogden - SVP of Finance and Accounting Sean McCarthy - CEO and Chairman Conference Call Participants Peter Lawson - Barclays Etzer Darout - BMO Capital Markets Mara Goldstein - Mizuho Group Mitchell Kapoor - H.C. Wainwright Joseph Catanzaro - Piper Operator Good day, and thank you for standing by. Welcome to the CytomX Therapeutics Third Quarter 2022 Financial Results Call. [Operato ...